Even if direct evidence is still lacking, considering that aromatase expression in AT is a marker of preadipocytes rather than mature adipocytes and that stimulation of PPARγ leads to a reduction in aromatase expression [111], it is likely that dedifferentiated CAAs are relevant sources of aromatase within the tumor microenvironment. The gene discussed is CYP19A1; the disease is neoplasm.